The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
ethyl 5-(4-((S)-3-(4-(2H-tetrazol-5-yl)phenylamino)-2-((1r,4S)-4-(aminomethyl)cyclohexanecarboxamido)-3-oxopropyl)phenyl)-6-methylpicolinate ID: ALA4541084
PubChem CID: 91667569
Max Phase: Preclinical
Molecular Formula: C33H38N8O4
Molecular Weight: 610.72
Molecule Type: Unknown
Associated Items:
Names and Identifiers Canonical SMILES: CCOC(=O)c1ccc(-c2ccc(C[C@H](NC(=O)[C@H]3CC[C@H](CN)CC3)C(=O)Nc3ccc(-c4nn[nH]n4)cc3)cc2)c(C)n1
Standard InChI: InChI=1S/C33H38N8O4/c1-3-45-33(44)28-17-16-27(20(2)35-28)23-8-4-21(5-9-23)18-29(37-31(42)25-10-6-22(19-34)7-11-25)32(43)36-26-14-12-24(13-15-26)30-38-40-41-39-30/h4-5,8-9,12-17,22,25,29H,3,6-7,10-11,18-19,34H2,1-2H3,(H,36,43)(H,37,42)(H,38,39,40,41)/t22-,25-,29-/m0/s1
Standard InChI Key: MVYPPJBYNQHFFT-HTLVZCCDSA-N
Molfile:
RDKit 2D
45 49 0 0 0 0 0 0 0 0999 V2000
3.7228 -13.9583 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.7228 -14.7755 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.4280 -15.1799 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.1333 -14.7755 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.1333 -13.9583 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.4280 -13.5456 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.4280 -12.7284 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.1357 -12.3198 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
3.7203 -12.3198 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
5.8435 -12.7284 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.5512 -12.3198 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.2589 -12.7284 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
6.5512 -11.5026 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
5.8435 -13.5456 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.5512 -13.9542 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.5472 -14.7724 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.2540 -15.1809 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.9627 -14.7723 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.9601 -13.9509 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.2526 -13.5460 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.6699 -15.1799 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.6696 -15.9982 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.3771 -16.4058 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.0852 -15.9962 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.0815 -15.1748 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
9.3735 -14.7709 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.3702 -13.9537 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.7940 -16.4029 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.7962 -17.2201 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
7.9666 -12.3198 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.4280 -15.9971 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.7203 -16.4057 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
8.6733 -12.7322 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.6683 -11.0978 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.9640 -11.5080 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.3804 -11.5018 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.3764 -12.3204 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.5006 -15.9924 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
12.2094 -16.3991 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.9160 -15.9887 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.0880 -11.0896 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.8350 -11.4210 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
11.3810 -10.8130 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
10.9715 -10.1057 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
10.1724 -10.2768 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
1 6 1 0
2 3 1 0
3 4 1 0
4 5 1 0
5 6 1 0
6 7 1 6
7 8 1 0
7 9 2 0
8 10 1 0
10 11 1 0
11 12 1 0
11 13 2 0
10 14 1 6
14 15 1 0
15 16 2 0
16 17 1 0
17 18 2 0
18 19 1 0
19 20 2 0
20 15 1 0
21 22 2 0
22 23 1 0
23 24 2 0
24 25 1 0
25 26 2 0
26 21 1 0
18 21 1 0
26 27 1 0
24 28 1 0
28 29 2 0
12 30 1 0
3 31 1 1
31 32 1 0
30 33 2 0
33 37 1 0
36 34 1 0
34 35 2 0
35 30 1 0
36 37 2 0
28 38 1 0
38 39 1 0
39 40 1 0
41 42 1 0
42 43 2 0
43 44 1 0
44 45 1 0
45 41 2 0
36 41 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 610.72Molecular Weight (Monoisotopic): 610.3016AlogP: 3.84#Rotatable Bonds: 11Polar Surface Area: 177.87Molecular Species: ZWITTERIONHBA: 9HBD: 4#RO5 Violations: 1HBA (Lipinski): 12HBD (Lipinski): 5#RO5 Violations (Lipinski): 2CX Acidic pKa: 5.94CX Basic pKa: 10.22CX LogP: 2.62CX LogD: 2.61Aromatic Rings: 4Heavy Atoms: 45QED Weighted: 0.18Np Likeness Score: -1.10
References 1. Steinmetzer T, Pilgram O, Wenzel BM, Wiedemeyer SJA.. (2020) Fibrinolysis Inhibitors: Potential Drugs for the Treatment and Prevention of Bleeding., 63 (4): [PMID:31658420 ] [10.1021/acs.jmedchem.9b01060 ]